Xenon Pharmaceuticals
A Company  Treating Chronic Pain

Xenon Pharmaceuticals (XENE) - a neuroscience-focused biopharmaceutical company dedicated to drug discovery, development, and commercialization of life-changing therapeutics for patients in need, announced equity inducement grants to seven new non-officer employees consisting of an aggregate of 55,300 share options.

Xenon’s lead molecule, azetukalner, azetukalner -  a novel, potent, selective Kv7 potassium channel opener in Phase . . .